bio

In his budget presentation to the legislature last week, Gov. Martin O’Malley called for continued support of his 10-year, $1 billion plan to build Maryland's reputation as a global leader in biosciences. To this end, the governor recommends $43 million in FY11 for stem cell research, tax credits for biotech companies, and support for biotechnology commercialization and translational research.

To help train future scientists and support cutting-edge research in health and environmental issues, Alaska Gov. Sean Parnell is recommending $109.5 million in the FY11 capital budget for the University of Alaska Life Sciences Facility in Fairbanks. The multi-purpose teaching and research facility would house the Department of Biology and Wildlife and accommodate a wide-range of research programs, reports Fairbanks Daily News-Miner. The proposal hinges on legislative approval of $88.9 million in financing through certificates of participation and $20.6 million in bond financing through the University of Alaska for construction, according to the governor’s press office. Read more at: http://www.gov.state.ak.us/news.php?id=5191.

During the last week of the legislative session, Nebraska Gov. Dave Heineman signed two bills into law - one dealing with R&D tax credits and the other authorizing the development of a statewide biotechnology strategic plan. The biotech plan, as outlined in LB 246, calls for the creation of a nonprofit corporation to provide research assistance and recommendations to the Legislature's Natural Resources Committee by June 30 of next year. A finalized plan must then be presented by the committee to the Legislature.

Gov. Charlie Crist signed Florida's $66.5 billion 2009-10 budget into law last week, providing a mixed bag of funding outcomes for the state's existing economic development programs.

The two main components of the Florida Biomedical Research Programs administered by the Florida Department of Health emerge with large funding increases. The James and Esther King Biomedical Research Program will be given $27.2 million from the state biomedical research trust fund in FY09-10, up from $9.9 million in the previous year. Similarly, the Bankhead-Coley Cancer Research Program will receive $25.0 million, an increase from $9.0 million last year.

A new report published by BIO, Battelle and the Biotechnology Institute finds that student achievement in biosciences varies widely between and within states. It also finds that many states lag behind in programmatic efforts to improve bioscience education, even as the life science industry grows in stature as a common priority for TBED initiatives.

DATELINE: PARIS

North Carolina's $1.2 billion dollar investment in bioscience over the past decade has helped to build a $45 billion dollar a year industry in the state, according to a new study released by the North Carolina Biotechnology Center. The report finds that North Carolina's bioscience employment numbers have grown 18.5 percent since 2001, the fastest in the nation. Much of this growth has been fueled by increased activity in research, testing and medical labs and in the agricultural feedstock and chemicals subsector. 

In the 2002 report Signs of Life: The Growth of Biotechnology Centers in the U.S., Joseph Cortright and Heike Mayer suggested it would take more than a decade for biotech investment strategies to yield fruit  - as measured by NIH funding and biocommercialization efforts. On the state level, with five years of NIH research funding data now available, some states can boast real percentage and actual dollar changes in the amount of NIH funding captured.

For several years governors across the country have announced life science and biotech initiatives that are as broad as they are large. The devil is in the details, and in most cases related to bio-based economic development, so are the opportunities. Participants in SSTI's 12th annual conference last week were reminded targeted investments in specialized areas related to merging existing life science and other technological strengths in a region are likely to have the greatest economic impact.

The demand for highly qualified talent in Massachusetts' bioscience industry will add more than 10,000 life sciences workers to the state's workforce by 2014, according to a recent report prepared by the University of Massachusetts Donahue Institute. As described in Growing Talent: Meeting the Evolving Needs of the Massachusetts Life Sciences Industry, 81 percent of these new life sciences jobs are expected to require at least a four-year degree. In preparation for this need, the report identifies the key challenges for increasing the quality and number of potential employees in the state, as well as policy recommendations for future growth.